Translational changes: evidence for low-dose atropine and myopia control
Abstract
Myopia control, as opposed to myopia correction, is emerging as the new standard of care for clinical management of paediatric myopia by optometrists. The prevalence of myopia, and high myopia, is increasing worldwide, while the prevalence of pathologies associated with myopia increases with increasing axial length. With increasing global prevalence, preventing the axial elongation and pathologies associated with higher levels of myopia is therefore of paramount importance. Pharmacological management with atropine is one of the key myopia control options available to practitioners. Management with 1% atropine shows positive control effects but induces significant visual side effects in paediatic patients due to cycloplegia and mydriasis. The initial studies on the efficacy of low-dose atropine (
Fields of Study & Subjects
Ophthalmology and Visual Impairment Studies
Retinopathy of Prematurity Studies
Glaucoma and retinal disorders
Publication details
- Journal / source
- Clinical and Experimental Optometry
- Publisher
- Informa UK Limited
- Volume
- 109
- Issue
- 6
- Pages
- 1129–1141
- Publication date
- 6 January 2026
- Language
- EN